High Levels of Free Triiodothyronine Associated with Reduced Alzheimer’s Risk in Patients with Cognitive Impairment

High Levels of Free Triiodothyronine Associated with Reduced Alzheimer’s Risk in Patients with Cognitive Impairment
High levels of free triiodothyronine — a type of thyroid hormone — are associated with a lower rate of Alzheimer’s disease risk in patients who have subjective or objective mild cognitive impairment, a new study shows. The study, “Low serum concentration of free triiodothyronine (FT3) is associated with increased risk of Alzheimer’s disease,” was published in the

Knowledge is power when living with alzheimers.

Get access to the web’s leading Alzheimer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *